Laura Mechtouff1, Norbert Nighoghossian2, Camille Amaz3, Marielle Buisson3, Yves Berthezène4, Laurent Derex1, Elodie Ong1, Omer Faruk Eker4, Tae-Hee Cho1. 1. Department of Neurology and Comprehensive Stroke Center, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Lyon, France. 2. Department of Neurology and Comprehensive Stroke Center, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Lyon, France. norbert.nighoghossian@chu-lyon.fr. 3. Clinical Investigation Center, INSERM 1407, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France. 4. Department of Neuroradiology, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Lyon, France.
Abstract
BACKGROUND AND PURPOSE: The significance of white matter hyperintensities (WMHs) in the setting of mechanical thrombectomy (MT) remains poorly documented. We assessed whether pre-existing WMHs burden was associated with baseline clinical and imaging factors and neurological outcome in patients undergoing MT. METHODS: This retrospective single-center study included consecutive acute ischemic stroke (AIS) patients with stroke due to large vessel occlusion treated with MT. WMHs were assessed on baseline T2 fluid-attenuated inversion recovery magnetic resonance imaging. Neurological outcome was assessed at day 90 by the modified Rankin Scale (mRS). We analyzed the association between WMH burden and clinical and imaging factors by univariate and multivariate logistic regression analyses. RESULTS: Between July 2013 and June 2019, 293 patients with anterior circulation AIS met the inclusion criteria. WMHs burden was not associated to baseline NIHSS score severity (OR 0.89, 95% CI 0.54-1.49, p = 0.66), poor collateral status, Higashida score < 3 (OR 1.5 95% CI 0.62-3.56, p = 0.36), higher DWI volume (OR 0.69, 95% CI 0.41-1.15, p = 0.16) or to a lower recanalization rate, TICI 0/2a (OR 0.98 95% CI 0.56-1.69, p = 0.95). WMHs severity did not influence the risk of parenchymal hemorrhage (OR 0.97 95% 0.26-3, p = 0.96). WMHs burden was not an independent predictor of poor outcome in multivariate analysis. The rate of futile recanalization in patients with TICI grades 2b and 3 according to mRs score at 3 months was not influenced by WMHs burden. CONCLUSIONS: WMHs burden does not seem to influence clinical outcome and imaging parameters in patients treated by MT.
BACKGROUND AND PURPOSE: The significance of white matter hyperintensities (WMHs) in the setting of mechanical thrombectomy (MT) remains poorly documented. We assessed whether pre-existing WMHs burden was associated with baseline clinical and imaging factors and neurological outcome in patients undergoing MT. METHODS: This retrospective single-center study included consecutive acute ischemic stroke (AIS) patients with stroke due to large vessel occlusion treated with MT. WMHs were assessed on baseline T2 fluid-attenuated inversion recovery magnetic resonance imaging. Neurological outcome was assessed at day 90 by the modified Rankin Scale (mRS). We analyzed the association between WMH burden and clinical and imaging factors by univariate and multivariate logistic regression analyses. RESULTS: Between July 2013 and June 2019, 293 patients with anterior circulation AIS met the inclusion criteria. WMHs burden was not associated to baseline NIHSS score severity (OR 0.89, 95% CI 0.54-1.49, p = 0.66), poor collateral status, Higashida score < 3 (OR 1.5 95% CI 0.62-3.56, p = 0.36), higher DWI volume (OR 0.69, 95% CI 0.41-1.15, p = 0.16) or to a lower recanalization rate, TICI 0/2a (OR 0.98 95% CI 0.56-1.69, p = 0.95). WMHs severity did not influence the risk of parenchymal hemorrhage (OR 0.97 95% 0.26-3, p = 0.96). WMHs burden was not an independent predictor of poor outcome in multivariate analysis. The rate of futile recanalization in patients with TICI grades 2b and 3 according to mRs score at 3 months was not influenced by WMHs burden. CONCLUSIONS:WMHs burden does not seem to influence clinical outcome and imaging parameters in patients treated by MT.
Entities:
Keywords:
Ischemic stroke; Magnetic resonance imaging; Thrombectomy; White matter
Authors: Gregory W Albers; Michael P Marks; Stephanie Kemp; Soren Christensen; Jenny P Tsai; Santiago Ortega-Gutierrez; Ryan A McTaggart; Michel T Torbey; May Kim-Tenser; Thabele Leslie-Mazwi; Amrou Sarraj; Scott E Kasner; Sameer A Ansari; Sharon D Yeatts; Scott Hamilton; Michael Mlynash; Jeremy J Heit; Greg Zaharchuk; Sun Kim; Janice Carrozzella; Yuko Y Palesch; Andrew M Demchuk; Roland Bammer; Philip W Lavori; Joseph P Broderick; Maarten G Lansberg Journal: N Engl J Med Date: 2018-01-24 Impact factor: 91.245
Authors: Raul G Nogueira; Ashutosh P Jadhav; Diogo C Haussen; Alain Bonafe; Ronald F Budzik; Parita Bhuva; Dileep R Yavagal; Marc Ribo; Christophe Cognard; Ricardo A Hanel; Cathy A Sila; Ameer E Hassan; Monica Millan; Elad I Levy; Peter Mitchell; Michael Chen; Joey D English; Qaisar A Shah; Frank L Silver; Vitor M Pereira; Brijesh P Mehta; Blaise W Baxter; Michael G Abraham; Pedro Cardona; Erol Veznedaroglu; Frank R Hellinger; Lei Feng; Jawad F Kirmani; Demetrius K Lopes; Brian T Jankowitz; Michael R Frankel; Vincent Costalat; Nirav A Vora; Albert J Yoo; Amer M Malik; Anthony J Furlan; Marta Rubiera; Amin Aghaebrahim; Jean-Marc Olivot; Wondwossen G Tekle; Ryan Shields; Todd Graves; Roger J Lewis; Wade S Smith; David S Liebeskind; Jeffrey L Saver; Tudor G Jovin Journal: N Engl J Med Date: 2017-11-11 Impact factor: 91.245
Authors: Esther M C van Leijsen; Mayra I Bergkamp; Ingeborg W M van Uden; Mohsen Ghafoorian; Helena M van der Holst; David G Norris; Bram Platel; Anil M Tuladhar; Frank-Erik de Leeuw Journal: Stroke Date: 2018-05-03 Impact factor: 7.914
Authors: Luis San Román; Bijoy K Menon; Jordi Blasco; María Hernández-Pérez; Antoni Dávalos; Charles B L M Majoie; Bruce C V Campbell; Francis Guillemin; Hester Lingsma; René Anxionnat; Jonathan Epstein; Jeffrey L Saver; Henk Marquering; John H Wong; Demetrius Lopes; Gernot Reimann; Hubert Desal; Diederik W J Dippel; Shelagh Coutts; Richard du Mesnil de Rochemont; Dileep Yavagal; Jean Christophe Ferre; Yvo B W E M Roos; David S Liebeskind; Robert Lenthall; Carlos Molina; Fahad S Al Ajlan; Vivek Reddy; Dar Dowlatshahi; Nader-Antoine Sourour; Catherine Oppenheim; Alim P Mitha; Stephen M Davis; Christian Weimar; Robert J van Oostenbrugge; Erik Cobo; Timothy J Kleinig; Geoffrey A Donnan; Aad van der Lugt; Andrew M Demchuk; Olvert A Berkhemer; Anna M M Boers; Gary A Ford; Keith W Muir; B Scott Brown; Tudor Jovin; Wim H van Zwam; Peter J Mitchell; Michael D Hill; Phil White; Serge Bracard; Mayank Goyal Journal: Lancet Neurol Date: 2018-09-18 Impact factor: 44.182
Authors: Susana Muñoz Maniega; Francesca M Chappell; Maria C Valdés Hernández; Paul A Armitage; Stephen D Makin; Anna K Heye; Michael J Thrippleton; Eleni Sakka; Kirsten Shuler; Martin S Dennis; Joanna M Wardlaw Journal: J Cereb Blood Flow Metab Date: 2016-07-21 Impact factor: 6.200
Authors: Mangmang Xu; Wen Guo; Lucie Rascle; Laura Mechtouff; Norbert Nighoghossian; Omer Eker; Lu Wang; Nils Henninger; Abdul Ghani Mikati; Shihong Zhang; Bo Wu; Ming Liu Journal: Front Neurol Date: 2022-06-24 Impact factor: 4.086
Authors: Christoph Johannes Griessenauer; David McPherson; Andrea Berger; Ping Cuiper; Nelson Sofoluke; Matthew D Adams; Saran Kunaprayoon; Ramin Zand; Jiang Li; Vida Abedi; Oded Goren; Clemens M Schirmer; Kathleen Donahue; Marco Nardin; Anne-Karin Giese; Markus D Schirmer; Natalia S Rost; Philipp Hendrix Journal: Cerebrovasc Dis Date: 2020-07-21 Impact factor: 2.762
Authors: Zimbul Albo; Jose Marino; Muhammad Nagy; Dilip K Jayaraman; Muhammad U Azeem; Ajit S Puri; Nils Henninger Journal: J Neurointerv Surg Date: 2020-05-15 Impact factor: 5.836